Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
horse chestnut (1 trial)
melissa officinalis (2 trials)
ranibizumab (lucentis) (1 trial)
Chronic Periodontitis (Phase 2)
Fatty Liver (Phase 2)
Macular Degeneration (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Periodontitis (Phase 2)
Trials (3 total)
Trial APIs (3 total)